CLEAR-ER was a multicenter , double-blind , randomized study ; rt-PA-eligible AIS patients were randomized to @ mg/kg rt-PA plus eptifibatide ( @ mcg/kg bolus and @ mcg/kg/min two-hour infusion ) versus standard rt-PA ( @ mg/kg ) .